ANG Lifesciences India Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 18.42 | 23.88 | 32.52 |
| Operating Expense | 18.03 | 25.89 | 29.70 |
| Net Profit | -1.94 | -4.57 | -1.07 |
| Net Profit Margin | -10.53 | -19.14 | -3.29 |
| Earning Per Share | -1.50 | -3.50 | -0.75 |
| EBIDTA | 1.41 | -1.02 | 2.42 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 18.42 |
| Operating Expense | 18.03 |
| Net Profit | -1.94 |
| Net Profit Margin | -10.53 |
| Earning Per Share | -1.50 |
| EBIDTA | 1.41 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 131.37 | 207.01 | 348.67 |
| Operating Expenses Annual | 122.25 | 195.94 | 283.59 |
| Operating Profit Annual | 8.22 | 20.91 | 66.03 |
| Interest Annual | 9.33 | 10.32 | 7.85 |
| Depreciation | 7.75 | 8.52 | 5.12 |
| Net Profit Annual | -8.65 | -0.66 | 39.71 |
| Tax Annual | -0.22 | 2.73 | 13.35 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 131.37 |
| Operating Expenses Annual | 122.25 |
| Operating Profit Annual | 8.22 |
| Interest Annual | 9.33 |
| Depreciation | 7.75 |
| Net Profit Annual | -8.65 |
| Tax Annual | -0.22 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.20 | 0.29 | 0.11 |
| Cash Flow from Operations | -13.13 | 26.01 | 27.39 |
| Cash Flow from Investing | 20.02 | -9.35 | -42.50 |
| Cash Flow from Financing | -7 | -16.75 | 15.29 |
| Cash Flow at the End | 0.09 | 0.20 | 0.29 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.20 |
| Cash Flow from Operations | -13.13 |
| Cash Flow from Investing | 20.02 |
| Cash Flow from Financing | -7 |
| Cash Flow at the End | 0.09 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 7.78 | 9.99 | 19.07 |
| PBIT Margin (%) | 1.88 | 5.87 | 17.60 |
| PBT Margin (%) | 1.69 | 5.33 | 15.48 |
| Net PROFIT Margin (%) | -6.58 | -0.32 | 11.39 |
| Return On Networth / Equity (%) | -8.72 | -0.46 | 63.62 |
| Return On Networth /Employed (%) | 1.71 | 7.81 | 49.10 |
| Return On Assets (%) | -5.99 | -0.42 | 31.78 |
| Total Debt / Equity (X) | 0.71 | 0.69 | 0.83 |
| Asset Turnover Ratio (%) | 0.91 | 1.33 | 2.79 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 7.78 |
| PBIT Margin (%) | 1.88 |
| PBT Margin (%) | 1.69 |
| Net PROFIT Margin (%) | -6.58 |
| Return On Networth / Equity (%) | -8.72 |
| Return On Networth /Employed (%) | 1.71 |
| Return On Assets (%) | -5.99 |
| Total Debt / Equity (X) | 0.71 |
| Asset Turnover Ratio (%) | 0.91 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 53.35 | 78.68 | 82.32 |
| Total Current Assets Annual | 158.37 | 168.21 | 181.57 |
| Non Current Assets Annual | 57.35 | 82.60 | 87.12 |
| Total Shareholders Funds Annual | 77.07 | 85.54 | 83.48 |
| Total Assets Annual | 217.43 | 252.51 | 268.68 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 53.35 |
| Total Current Assets Annual | 158.37 |
| Non Current Assets Annual | 57.35 |
| Total Shareholders Funds Annual | 77.07 |
| Total Assets Annual | 217.43 |
EPS (INR)
Expected
-1.58
Reported
-1.56
Surprise
-1.27%
Dec 2024
EPS beaten by -1.27%
Sep 2024
EPS beaten by 0.25%
Jun 2024
EPS beaten by 0.00%
